Status:
UNKNOWN
Multi-scale Modeling of Breast Conserving Therapy
Lead Sponsor:
The Methodist Hospital Research Institute
Conditions:
Breast Cancer
Eligibility:
FEMALE
30-80 years
Brief Summary
The proposed study is a single-center, prospective, pilot, observation study to tabulate and measure the changes that occur during treatment and healing for breast conserving therapy (BCT) in women wi...
Detailed Description
This is a single-center, prospective, pilot observation study. Eligible subjects who enroll in this study will begin at the time of informed consent, which will occur during the pre-operative, surgica...
Eligibility Criteria
Inclusion
- Adult females ≥ age 30 years
- Have early stage (Stage I, II), non-metastatic breast cancer
- Planned to receive BCT
- Have received a pre-operative mammogram within 30 days of surgery
- Have received pre-operative magnetic resonance imaging (MRI) within 30 days of surgery
- Planned to receive post-surgery radiotherapy by whole breast radiotherapy
- Signed informed consent form prior to any research assessment
Exclusion
- Adult females younger than 30 years of age
- Previous breast cancer
- Neo-adjuvant therapy for breast cancer
- Pregnant or nursing females
- Participation in a study of investigational drug in the previous 30 days or 5 half-lives of the investigational drug
Key Trial Info
Start Date :
May 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2020
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT02310711
Start Date
May 1 2012
End Date
August 1 2020
Last Update
October 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Houston Methodist Hopsital
Houston, Texas, United States, 77030